Proto Labs, Inc. |
|||||||||||
Condensed Consolidated Statements of Cash Flows |
|||||||||||
(In thousands) |
|||||||||||
(Unaudited) |
|||||||||||
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
Three Months Ended |
||||||
|
|
|
|
|
March 31, |
||||||
|
|
|
|
|
2020 |
|
2019 |
||||
| Operating activities | |||||||||||
| Net income | $ |
13,984 |
|
$ |
15,511 |
|
|||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Depreciation and amortization |
|
7,958 |
|
|
7,439 |
|
|||||
| Stock-based compensation expense |
|
3,033 |
|
|
3,040 |
|
|||||
| Deferred taxes |
|
3,392 |
|
|
379 |
|
|||||
| Amortization of held-to-maturity securities |
|
55 |
|
|
16 |
|
|||||
| Other |
|
(644 |
) |
|
236 |
|
|||||
| Changes in operating assets and liabilities |
|
(5,368 |
) |
|
(8,619 |
) |
|||||
| Net cash provided by operating activities |
|
22,410 |
|
|
18,002 |
|
|||||
| Investing activities | |||||||||||
| Purchases of property, equipment and other capital assets |
|
(13,421 |
) |
|
(12,735 |
) |
|||||
| Cash used for acquisitions, net of cash acquired |
|
- |
|
|
- |
|
|||||
| Purchases of other assets and investments |
|
(3,000 |
) |
|
(4,000 |
) |
|||||
| Purchases of marketable securities |
|
(37,629 |
) |
|
- |
|
|||||
| Proceeds from maturities of marketable securities |
|
10,700 |
|
|
17,006 |
|
|||||
| Net cash (used in) provided by investing activities |
|
(43,350 |
) |
|
271 |
|
|||||
| Financing activities | |||||||||||
| Proceeds from exercises of stock options and other |
|
135 |
|
|
174 |
|
|||||
| Purchases of shares withheld for tax obligations |
|
(1,048 |
) |
|
(594 |
) |
|||||
| Repurchases of common stock |
|
(11,185 |
) |
|
(17,309 |
) |
|||||
| Net cash used in financing activities |
|
(12,098 |
) |
|
(17,729 |
) |
|||||
| Effect of exchange rate changes on cash and cash equivalents |
|
(282 |
) |
|
(240 |
) |
|||||
| Net (decrease) increase in cash and cash equivalents |
|
(33,320 |
) |
|
304 |
|
|||||
| Cash and cash equivalents, beginning of period |
|
125,225 |
|
|
85,046 |
|
|||||
| Cash and cash equivalents, end of period | $ |
91,905 |
|
$ |
85,350 |
|
|||||
|
Protolabs Reports Financial Results for the First Quarter 2020
|
|
||||||
|
|
|||||||
|
|||||||
